SYS-CON MEDIA Authors: Jason Bloomberg, Sandi Mappic, RealWire News Distribution, Kevin Benedict, Bob Gourley

News Feed Item

Medivation Founder, President and Chief Executive Officer David Hung, M.D. Named an EY Entrepreneur Of The Year(TM) 2014 Award Winner in Northern California

Award Recognizes Entrepreneurial Excellence in the Life Sciences Category

SAN FRANCISCO, CA -- (Marketwired) -- 06/11/14 -- Medivation, Inc. (NASDAQ: MDVN) announced today that Founder, President and CEO David Hung, M.D. has received an EY Entrepreneur Of The Year™ 2014 Award in the Life Sciences category in Northern California. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Dr. Hung was selected by a panel of independent judges and honored at a special gala event on June 10 at the Fairmont San Jose.

"Our unrelenting focus on outstanding science, elegant clinical research, and accelerated development and commercialization has allowed Medivation to break important new ground in prostate cancer and continue to advance our development programs in other serious diseases," said Dr. Hung. "I gratefully accept this award on behalf of the entire Medivation team and dedicate it to the thousands of courageous men with prostate cancer who have participated in our clinical trials to help make a novel life-extending therapy available."

Now in its 28th year, the program has expanded to recognize business leaders in more than 150 cities in more than 60 countries throughout the world.

As a Northern California award winner, Dr. Hung is now eligible for consideration for the National Entrepreneur Of The Year 2014 Award. Award winners in several national categories, as well as the National Entrepreneur Of The Year Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 15, 2014. The awards are the culminating event of the EY Strategic Growth Forum®, the nation's most prestigious gathering of high-growth, market-leading companies.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, visit www.medivation.com.

About EY Entrepreneur Of The Year™
EY Entrepreneur Of The Year™ is the world's most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 150 cities in more than 60 countries.

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

Contacts:
Mike Beyer
(media)
Sam Brown, Inc.
(773) 463-4211

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.